Topline data were published from a phase 2b/3 study evaluating blarcamesine for the treatment of early Alzheimer disease.

A new meta-analysis adds to the body of literature promoting the benefits of exercise for patients with cancer.

The coprimary endpoints were the change from baseline in cognitive decline (using the 13-item Alzheimer Disease Assessment Scale-Cognition [ADAS-Cog13]) and functional decline (using the ...

When education leadership and training are commandeered by those who dismiss the traditional work of schooling, learning ...

Heavy lifetime cannabis use is associated with reduced brain activation in key cognitive regions, particularly during working ...

Researchers identified two groups of children with opposing support needs and symptom severity who are more likely to be ...

How rigorous testing environments can boost user satisfaction and business outcomes In the contemporary AI landscape, match ...

Horizon Kinetics have published their Q4 2024 Commentary. How’d we do? How’d the market do? What to expect now? Click here to ...

A new study published in the Journal of Affective Disorders shows that individuals with depression exhibit slower and less ...

The Georgia General Assembly got off to a fast start on Monday with the State Senate taking up its first substantive measures ...

The HUMANOID Center at UC San Diego is pioneering organoid research aimed at improving the reliability and reproducibility of ...